The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2024, balance sheet FY2025, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
Financials view
Market Capitalization
1.56BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Trailing P/E
6.10x
vs Chemicals peers
Updated Jul 17, 2026
Revenue (TTM)
1.19BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Profit Margin
10.34%
vs Chemicals peers
Updated Jul 17, 2026
Beta
0.5890x
vs all stocks
Updated Jul 17, 2026
52-Week Change
5.67%
vs all stocks
Updated Jul 17, 2026
Market Capitalization
1.56BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Enterprise Value
91.16MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Trailing P/E
6.10x
vs Chemicals peers
Updated Jul 17, 2026
Price to Sales (TTM)
0.1927x
vs Chemicals peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.31×.Updated Jul 17, 2026
Price to Book (MRQ)
0.5516x
vs Chemicals peers
Updated Jul 17, 2026
Enterprise to Revenue
0.0760x
vs Chemicals peers
Updated Jul 17, 2026
Enterprise to EBITDA
0.5720x
vs Chemicals peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 0.09×.Updated Jul 17, 2026
Gross Margin
15.56%
vs Chemicals peers
Updated Jul 17, 2026
Profit Margin
10.34%
vs Chemicals peers
Updated Jul 17, 2026
Operating Margin
7.75%
vs Chemicals peers
Updated Jul 17, 2026
Return on Assets (TTM)
2.95%
vs Chemicals peers
Updated Jul 17, 2026
Return on Equity (TTM)
9.07%
vs Chemicals peers
Updated Jul 17, 2026
Revenue (TTM)
1.19BUSD
vs all stocks (USD)
Updated Jul 17, 2026
Revenue per Share (TTM)
7.00USDUpdated Jul 17, 2026
Quarterly Revenue Growth
15.60%
vs Chemicals peers
Updated Jul 17, 2026
Gross Profit (TTM)
184.04MUSD
vs all stocks (USD)
Updated Jul 17, 2026
EBITDA (TTM)
978.79MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Net Income (TTM)
123.52MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Quarterly Earnings Growth (YoY)
-11.10%
vs Chemicals peers
Updated Jul 17, 2026
Operating Cash Flow (TTM)
253.96MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Levered Free Cash Flow (TTM)
-216.74MUSD
vs all stocks (USD)
Updated Jul 17, 2026
5-Year Average Dividend Yield
6.07%
vs all stocks
Updated Jul 17, 2026
Payout Ratio
29.11%
vs Chemicals peers
Updated Jul 17, 2026
Revenue
8.18BCNYFY2024 · Dec 31, 2024
Cost of Goods Sold
6.72BCNYFY2024 · Dec 31, 2024
Gross Profit
1.47BCNYFY2024 · Dec 31, 2024
Operating Income
802.03MCNY
118.89M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Pre-tax Income
906.89MCNYFY2024 · Dec 31, 2024
Income Tax Expense
78.82MCNYFY2024 · Dec 31, 2024
Net Income
828.07MCNYFY2024 · Dec 31, 2024
EBIT
949.52MCNYFY2024 · Dec 31, 2024
EBITDA (Income Statement)
1.48BCNYFY2024 · Dec 31, 2024
Research & Development
290.99MCNYFY2024 · Dec 31, 2024
Selling, General & Administrative
229.34MCNYFY2024 · Dec 31, 2024
Other Operating Expenses
27.09MCNYFY2024 · Dec 31, 2024
Non-operating Interest Income
49.85MCNYFY2024 · Dec 31, 2024
Non-operating Interest Expense
42.63MCNYFY2024 · Dec 31, 2024
EPS (Basic)
0.6809CNYFY2024 · Dec 31, 2024
EPS (Diluted)
0.6809CNYFY2024 · Dec 31, 2024
Basic Shares Outstanding
1.16BSharesFY2024 · Dec 31, 2024
Diluted Shares Outstanding
1.16BSharesFY2024 · Dec 31, 2024
Net Income from Continuing Operations
828.07MCNYFY2024 · Dec 31, 2024
Minority Interests (P&L)
-40.69MCNYFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00CNYFY2024 · Dec 31, 2024
Operating Cash Flow
310.29MCNYFY2024 · Dec 31, 2024
Free Cash Flow
-495.63MCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
2.63BCNYFY2024 · Dec 31, 2024
Starting Profit (CF Statement)
828.07MCNYFY2024 · Dec 31, 2024
Other Non-cash Items
82.96MCNYFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-560.49MCNYFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-40.25MCNYFY2024 · Dec 31, 2024
Capital Expenditures
-805.92MCNYFY2024 · Dec 31, 2024
Sale of Investments
587.48MCNYFY2024 · Dec 31, 2024
Net Investing Cash Flow
-218.44MCNYFY2024 · Dec 31, 2024
Long-term Debt Issuance
715.84MCNYFY2024 · Dec 31, 2024
Long-term Debt Payments
-1.67BCNYFY2024 · Dec 31, 2024
Common Dividends Paid
-265.82MCNYFY2024 · Dec 31, 2024
Other Financing Charges
-692.40MCNYFY2024 · Dec 31, 2024
Net Financing Cash Flow
-1.91BCNYFY2024 · Dec 31, 2024
Shares Outstanding
1.16BSharesUpdated Jul 17, 2026
Float Shares
617.58MSharesUpdated Jul 17, 2026
% Held by Insiders
0.00%
vs all stocks
Updated Jul 17, 2026
% Held by Institutions
9.95%
vs all stocks
Updated Jul 17, 2026
Total Cash (MRQ)
320.50MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Total Cash per Share (MRQ)
1.88USDUpdated Jul 17, 2026
Total Debt (MRQ)
297.15MUSD
vs all stocks (USD)
Updated Jul 17, 2026
Total Debt to Equity (MRQ)
0.2116x
vs Chemicals peers
Updated Jul 17, 2026
Current Ratio (MRQ)
1.27x
vs Chemicals peers
Updated Jul 17, 2026
Book Value per Share (MRQ)
1.22USDUpdated Jul 17, 2026
Cash Equivalents
807.96MCNYFY2025 · Dec 31, 2025
52-Week Low
0.6060USDUpdated Jul 17, 2026
52-Week High
0.7490USDUpdated Jul 17, 2026
52-Week Change
5.67%
vs all stocks
Updated Jul 17, 2026
Beta
0.5890x
vs all stocks
Updated Jul 17, 2026
50-Day MA
0.6617USDUpdated Jul 17, 2026
200-Day MA
0.6867USDUpdated Jul 17, 2026
Avg 10-Day Volume
490.29KSharesUpdated Jul 17, 2026
Avg 30-Day Volume
744.45KSharesUpdated Jul 17, 2026
Diluted EPS (TTM)
0.1100USDUpdated Jul 17, 2026
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 6.1×, lower than 95% of its Chemicals peers (median 44.39×)Notable